← Leaderboards
Hang Hubert Yin
University Of Colorado
$4,493,033
Attributed
$4,806,123
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $903.9K · FY2009–18$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$4,806,123 · 8
By mechanism
R01$2,754,150 · 2
R21$1,351,639 · 3
R03$454,121 · 2
R35$246,213 · 1
Top collaborators
- Jennifer M Martin7 shared
Others in their field
Top investigators on “Insight”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- James Dennis Neaton · Northwestern University$283,212,546
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$278,513,775
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
Research focus
InsightMediatingMembraneDesignSignal PathwayInhibitor/AntagonistInnovationSmall MoleculeSignal TransductionPeptidesTechnologyMolecular RecognitionDependenceLigandsProteinsLightIn VitroPreventPharmaceutical PreparationsBinding (Molecular Function)New Therapeutic TargetGenerationsClinically RelevantAssay Development
Grant awards (26)
Chemical Tools for Studying Membrane Protein Interactions$246,213
R35 · FY2018 · GM · contact PI
Exogenous Chemical Probes of TLR-Mediated Neuroinflammation$289,750
R01 · FY2017 · GM · contact PI
Dissecting Cell Signaling Mediated by Protein-Protein Interactions in Membranes$295,850
R01 · FY2016 · GM · contact PI
Exogenous Chemical Probes of TLR-Mediated Neuroinflammation$289,750
R01 · FY2016 · GM · contact PI
Dissecting Cell Signaling Mediated by Protein-Protein Interactions in Membranes$362,950
R01 · FY2015 · GM · contact PI
Exogenous Chemical Probes of TLR-Mediated Neuroinflammation$289,750
R01 · FY2015 · GM · contact PI
Exogenous Chemical Probes of TLR-Mediated Neuroinflammation$289,750
R01 · FY2014 · GM · contact PI
Dissecting Cell Signaling Mediated by Protein-Protein Interactions in Membranes$289,750
R01 · FY2014 · GM · contact PI
Dissecting Cell Signaling Mediated by Protein-Protein Interactions in Membranes$67,100
R01 · FY2014 · GM · contact PI
Dissecting Cell Signaling Mediated by Protein-Protein Interactions in Membranes$289,750
R01 · FY2013 · GM · contact PI
Exogenous Chemical Probes of TLR-Mediated Neuroinflammation$289,750
R01 · FY2013 · GM · contact PI
Developing Small-Molecule Probes for Opioid-Induced Glial Activation$224,978
R21 · FY2010 · NS · contact PI
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago$197,445
R21 · FY2010 · CA · contact PI
Transforming Clinical Pain Control by Targeting a Novel Non-Neuronal Receptor$189,375
R03 · FY2010 · DA · contact PI
Optimizing the Clinical Efficacy of Opioids by TLR4 Blockade$137,227
R21 · FY2010 · DA · contact PI
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago$57,679
R21 · FY2010 · CA · contact PI
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago$57,679
R21 · FY2010 · CA · contact PI
Probing Opioid-Induced Glial Activation with Peptide Antagonists$37,496
R03 · FY2010 · DA · contact PI
Developing Small-Molecule Probes for Opioid-Induced Glial Activation$227,250
R21 · FY2009 · NS · contact PI
Transforming Clinical Pain Control by Targeting a Novel Non-Neuronal Receptor$189,375
R03 · FY2009 · DA · contact PI
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago$164,189
R21 · FY2009 · CA · contact PI
Optimizing the Clinical Efficacy of Opioids by TLR4 Blockade$136,003
R21 · FY2009 · DA · contact PI
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago$54,050
R21 · FY2009 · CA · contact PI
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago$49,535
R21 · FY2009 · CA · contact PI
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago$45,604
R21 · FY2009 · CA · contact PI
Probing Opioid-Induced Glial Activation with Peptide Antagonists$37,875
R03 · FY2009 · DA · contact PI